OncoSenX
Gary Hudson is co-founder and Board Member of OncoSenX. Mr. Hudson is also active in several non-profits focusing on age-related disease. Mr. Hudson has won several awards during his career including Laurel Award from Aviation Week and Space Technology, the Founder’s Award from the Space Frontier Foundation and was inducted into the International Space Hall of Fame in 2014 for his contributions to the field.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
OncoSenX
OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.